Clinical trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis
NCT03451045 is registered in ClinicalTrials.gov with Corbus Pharmaceuticals Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis
- Lead sponsor
- Corbus Pharmaceuticals Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 22, 2017
- Completion date
- June 17, 2020
- Enrollment
- 447 (actual)
- Sites
- 105
Conditions
As the registry lists them; a condition with its own page is linked.